Pierre Duez
Full Professor. University of Mons (UMONS).
Director of the Unit of Therapeutic Chemistry and Pharmacognosy Vice-Rector for International Relations and Mobility Université de Mons (UMONS) Bât. 6, Chemin du Champ de Mars 25 7000 Mons 1. EDUCATION Secondary School 1971 – 1977 Athénée Royal de Mons (lat.-maths) Candidate in Pharmaceutical Sciences 1977 – 1979 Université de l’Etat à Mons Pharmacist 1979 – 1982 Université Libre de Bruxelles Doctor in Biomedical and Pharmaceutical Sciences 2001 Université Libre de Bruxelles Belgian Industrial Pharmacist, Number 972 2. PROFESSIONAL ACTIVITIES • 1982 – 1991 (1.0 FTE) : ULB, Institute of Pharmacy, Service de Chimie Analytique, Chimie Pharmaceutique Inorganique et Toxicologie, researcher (cooperation with Burkina Faso) • 1985 – 1986 (1.0 FTE) : Military duty (Central Pharmacy QC, Nivelles, Belgium) • 1992 – 1993 (1.0 FTE) : GDM Green s.a., research and quality control • 1993 – 2002 (0.5 FTE) : ULB, Institute of Pharmacy, Laboratoire de Biochimie Clinique, Assistant • 1993 – 1996 (0.5 FTE) : Schering-Plough International, Regulatory Affairs. • 1996 – 2002 (0.5 FTE) : ULB, Institute of Pharmacy, Laboratoire de Chimie Bioanalytique, de Toxicologie et de Chimie Physique Appliquée, Assistant • 2002 – 2013 (1.0 FTE) : ULB, Institute of Pharmacy, Professor, Head of the Laboratoire de Pharmacognosie, de Bromatologie et de Nutrition humaine • 2006 – 2013 (0.2 FTE) : UMONS, Faculté de Médecine et de Pharmacie, Professor, Head of the Service de Chimie Thérapeutique et Pharmacognosie. • Since 2013 (1.0 FTE) : UMONS, Faculté de Médecine et de Pharmacie, Professor, Head of the Service de Chimie Thérapeutique et Pharmacognosie. • Since 2016 (1.0 FTE) : UMONS, Faculté de Médecine et de Pharmacie, Full Professor, Head of the Service de Chimie Thérapeutique et Pharmacognosie. 3. EXPERTISE • Member of the European Pharmacopoeia TCM expert group • Member of the European Medicine Agency MLWP-HMPC expert group • Member of the Belgian Commission of Pharmacopoeia, Chairman of 2 sub-committees • Member of the Belgian Commission for Registration of Herbal Medicines (2013-2019) • Chairman of the Commission for International Relations (CRI) of the Académie de Recherche et d’Enseignement Supérieur (ARES), Wallonia-Brussels Federation. • Chairman of the Commission for International Relations (CRI) of the Fonds national de Recherche Scientifique (FNRS). • Scientific missions and/or cooperation activities in Algeria, Argentina, Burkina Faso, Cameroun, France, Germany, Uganda, Syria. • Cooperation and/or research programs with Burkina Faso, PR China, DR Congo, Ecuador, Madagascar, Rwanda, UK, Vietnam. • Board member of the GP-TCM research association (http://www.gp-tcm.org/); head of the pharmacology and toxicology interest group (http://www.gp-tcm.org/work-packages/wp3-functional-genomics-intoxicology-study-of-chinese-herbal-medicines/). • Member of the Specialty Committee for the Evaluation of Postmarketing Chinese Medicines (World Federation of Chinese Medicine Societies, WFCMS). • Member of the Specialty Committee of TCM Pharmaceutical Analysis (World Federation of Chinese Medicine Societies, WFCMS) • Member of the Science and Technology Development Committee (World Federation of Chinese Medicine Societies, WFCMS). • Evaluation of research projects for the European Commission (FP6 and FP7), the Belgian authorities, the Austrian authorities, the Hong Kong Research Grants Council, the International Fundation for Science (IFS, Sweden), the Groupement des Hôpitaux Universitaires du Grand Ouest (HUGO, France), the Medical Research Council (UK), the Icelandic Research Fund. • Consultant for the European DG TAXUD (Directorate-General for Taxation and Customs Union); customs classification of herbal products. 4. RECENT AND ON-GOING PROJECTS • Projet AI ARES-CCD “Programme d’appui institutionnel avec l’Université de Lubumbashi” • Projet PRD ARES-CCD “Diabiomal: Implantation d’une méthode robuste, peu onéreuse pour le diagnostic de la malaria et application à la recherche bioguidée de nouveaux antimalariques” • Projet Fonds de Maturation Région Wallonne “Hemozdiag: Développement et commercialisation d’un dispositif original de diagnostic de la malaria” • Projet PII ARES-CCD “PII – Développement d’une unité de neurologie pour l’étude des effets neurotoxiques du cobalt et d’autres métaux dans la région du Katanga” • Projet PRD ARES-CCD “NEUROKAT: renforcement de la capacité opérationnelle et de la formation en neuropsychiatrie par l’étude des effets neurotoxiques de métaux dans la région minière du Katanga” (Promotor, L. Ris, UMONS) • Projet PRD ARES-CCD “PHYTOKAT: Conditions pour l’intégration de la médecine traditionnelle aux soins de santé modernes: caractérisation, validation biologique et culture ex situ de plantes médicinales” • Projet PRD ARES-CCD “Exploring the medical, (eco)-toxicological and socio-economic potential of natural extracts in North Vietnam” (Promotor, M. Muller, ULg) 5. SCIENTIFIC PUBLICATIONS Supervisor and co-supervisor of 24 defended PhD theses, 9 master (3rd cycle) theses and 94 master theses; 43 participations in PhD Juries. Co-editor of 1 book (“Toxicology of Herbal Products”, Springer), author and co-author of 9 didactical books, 180 scientific papers, 11 book chapters, 1 patent, 1 report for the European Development Fund and 338 communications in national and international meetings, congresses and symposiums. Organizer of the 2015 GP-TCM RA meeting in Mons, Belgium (~ 160 international participants with ~ 50 from China).
Director of the Unit of Therapeutic Chemistry and Pharmacognosy Vice-Rector for International Relations and Mobility Université de Mons (UMONS) Bât. 6, Chemin du Champ de Mars 25 7000 Mons 1. EDUCATION Secondary School 1971 – 1977 Athénée Royal de Mons (lat.-maths) Candidate in Pharmaceutical Sciences 1977 – 1979 Université de l’Etat à Mons Pharmacist 1979 – 1982 Université Libre de Bruxelles Doctor in Biomedical and Pharmaceutical Sciences 2001 Université Libre de Bruxelles Belgian Industrial Pharmacist, Number 972 2. PROFESSIONAL ACTIVITIES • 1982 – 1991 (1.0 FTE) : ULB, Institute of Pharmacy, Service de Chimie Analytique, Chimie Pharmaceutique Inorganique et Toxicologie, researcher (cooperation with Burkina Faso) • 1985 – 1986 (1.0 FTE) : Military duty (Central Pharmacy QC, Nivelles, Belgium) • 1992 – 1993 (1.0 FTE) : GDM Green s.a., research and quality control • 1993 – 2002 (0.5 FTE) : ULB, Institute of Pharmacy, Laboratoire de Biochimie Clinique, Assistant • 1993 – 1996 (0.5 FTE) : Schering-Plough International, Regulatory Affairs. • 1996 – 2002 (0.5 FTE) : ULB, Institute of Pharmacy, Laboratoire de Chimie Bioanalytique, de Toxicologie et de Chimie Physique Appliquée, Assistant • 2002 – 2013 (1.0 FTE) : ULB, Institute of Pharmacy, Professor, Head of the Laboratoire de Pharmacognosie, de Bromatologie et de Nutrition humaine • 2006 – 2013 (0.2 FTE) : UMONS, Faculté de Médecine et de Pharmacie, Professor, Head of the Service de Chimie Thérapeutique et Pharmacognosie. • Since 2013 (1.0 FTE) : UMONS, Faculté de Médecine et de Pharmacie, Professor, Head of the Service de Chimie Thérapeutique et Pharmacognosie. • Since 2016 (1.0 FTE) : UMONS, Faculté de Médecine et de Pharmacie, Full Professor, Head of the Service de Chimie Thérapeutique et Pharmacognosie. 3. EXPERTISE • Member of the European Pharmacopoeia TCM expert group • Member of the European Medicine Agency MLWP-HMPC expert group • Member of the Belgian Commission of Pharmacopoeia, Chairman of 2 sub-committees • Member of the Belgian Commission for Registration of Herbal Medicines (2013-2019) • Chairman of the Commission for International Relations (CRI) of the Académie de Recherche et d’Enseignement Supérieur (ARES), Wallonia-Brussels Federation. • Chairman of the Commission for International Relations (CRI) of the Fonds national de Recherche Scientifique (FNRS). • Scientific missions and/or cooperation activities in Algeria, Argentina, Burkina Faso, Cameroun, France, Germany, Uganda, Syria. • Cooperation and/or research programs with Burkina Faso, PR China, DR Congo, Ecuador, Madagascar, Rwanda, UK, Vietnam. • Board member of the GP-TCM research association (http://www.gp-tcm.org/); head of the pharmacology and toxicology interest group (http://www.gp-tcm.org/work-packages/wp3-functional-genomics-intoxicology-study-of-chinese-herbal-medicines/). • Member of the Specialty Committee for the Evaluation of Postmarketing Chinese Medicines (World Federation of Chinese Medicine Societies, WFCMS). • Member of the Specialty Committee of TCM Pharmaceutical Analysis (World Federation of Chinese Medicine Societies, WFCMS) • Member of the Science and Technology Development Committee (World Federation of Chinese Medicine Societies, WFCMS). • Evaluation of research projects for the European Commission (FP6 and FP7), the Belgian authorities, the Austrian authorities, the Hong Kong Research Grants Council, the International Fundation for Science (IFS, Sweden), the Groupement des Hôpitaux Universitaires du Grand Ouest (HUGO, France), the Medical Research Council (UK), the Icelandic Research Fund. • Consultant for the European DG TAXUD (Directorate-General for Taxation and Customs Union); customs classification of herbal products. 4. RECENT AND ON-GOING PROJECTS • Projet AI ARES-CCD “Programme d’appui institutionnel avec l’Université de Lubumbashi” • Projet PRD ARES-CCD “Diabiomal: Implantation d’une méthode robuste, peu onéreuse pour le diagnostic de la malaria et application à la recherche bioguidée de nouveaux antimalariques” • Projet Fonds de Maturation Région Wallonne “Hemozdiag: Développement et commercialisation d’un dispositif original de diagnostic de la malaria” • Projet PII ARES-CCD “PII – Développement d’une unité de neurologie pour l’étude des effets neurotoxiques du cobalt et d’autres métaux dans la région du Katanga” • Projet PRD ARES-CCD “NEUROKAT: renforcement de la capacité opérationnelle et de la formation en neuropsychiatrie par l’étude des effets neurotoxiques de métaux dans la région minière du Katanga” (Promotor, L. Ris, UMONS) • Projet PRD ARES-CCD “PHYTOKAT: Conditions pour l’intégration de la médecine traditionnelle aux soins de santé modernes: caractérisation, validation biologique et culture ex situ de plantes médicinales” • Projet PRD ARES-CCD “Exploring the medical, (eco)-toxicological and socio-economic potential of natural extracts in North Vietnam” (Promotor, M. Muller, ULg) 5. SCIENTIFIC PUBLICATIONS Supervisor and co-supervisor of 24 defended PhD theses, 9 master (3rd cycle) theses and 94 master theses; 43 participations in PhD Juries. Co-editor of 1 book (“Toxicology of Herbal Products”, Springer), author and co-author of 9 didactical books, 180 scientific papers, 11 book chapters, 1 patent, 1 report for the European Development Fund and 338 communications in national and international meetings, congresses and symposiums. Organizer of the 2015 GP-TCM RA meeting in Mons, Belgium (~ 160 international participants with ~ 50 from China).